✦ LIBER ✦

Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: A meta-analysis

✍ Scribed by Matteo Monami; Niccolò Marchionni; Edoardo Mannucci

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-acting insulin analogues vs. NPH hu

✍ M. Monami; N. Marchionni; E. Mannucci 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

Short-acting insulin analogues vs. regul

✍ E. Mannucci; M. Monami; N. Marchionni 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Direct healthcare costs of patients with

✍ Jens Gundgaard; Torsten E. Christensen; Trine Lyager Thomsen 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 204 KB

Reduced Hypoglycemia Risk With Insulin G

✍ Rosenstock, J.; Dailey, G.; Massi-Benedetti, M.; Fritsche, A.; Lin, Z.; Salzman, 📂 Article 📅 2005 🏛 American Diabetes Association 🌐 English ⚖ 99 KB

Insulin therapy in type 2 diabetes: role

✍ H. Yki-Järvinen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

Meta-analysis of short-acting insulin an

✍ A. Siebenhofer; J. Plank; A. Berghold; K. Horvath; P. T. Sawicki; P. Beck; T. R. 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 238 KB